Protara Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:TARA) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities -8.43 M-9.31 M-14.71 M-12.25 M-12.45 M -48.72 M Cash from investing activities -29.39 M22.5 M-58.35 M-47.72 M-6.51 M -90.08 M Cash from financing activities 097.85 M1.73 M8 00013 K 99.6 M Free cash flow -8.44 M-9.31 M-14.76 M-12.27 M-12.46 M -48.79 M

Notícias

Protara Therapeutics, Inc. (TARA) Presents at 2026 ASCO Genitourinary Cancers Symposium - Slideshow (NASDAQ:TARA) 2026-02-26

AMD and Keysight Technologies among market cap stock movers on Tuesday

AMD, IBM among market cap stock movers on Tuesday

What's Going On With Protara Therapeutics Stock Tuesday? - Protara Therapeutics (NASDAQ:TARA)

Protara Therapeutics hisseleri deneme verileriyle düştü

Protara Therapeutics stock tumbles on trial data release

Protara mesane kanseri denemesinden ara sonuçları açıkladı

Protara reports interim results from bladder cancer trial

Protara to present bladder cancer treatment data at ASCO symposium

Protara Therapeutics, Inc. (TARA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:TARA) 2026-01-15

Protara Therapeutics, Inc. (TARA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Protara to report interim results from BCG-unresponsive trial in Q1